Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials

Published:2021-06 Issue:6 Volume:8 Page:471-486
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Højlund Mikkel^ORCID,Kemp Adam F^ORCID,Haddad Peter M^ORCID,Neill Joanna C^ORCID,Correll Christoph U^ORCID

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference49 articles.

1. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials;Leucht;Am J Psychiatry,2003

2. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis;Leucht;Lancet,2012

3. Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms;Shimomura;Schizophr Res,2020

4. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial;Wunderink;JAMA Psychiatry,2013

5. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?;Correll;World Psychiatry,2018

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction;Psychiatric Services;2024-06-19

2. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline;Neuropsychiatric Disease and Treatment;2024-06

3. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia;European Neuropsychopharmacology;2024-05

4. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia;Schizophrenia Research;2024-05

5. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series;BMC Psychiatry;2024-03-29